Related Experiment Videos
High-dose chemotherapy in poor-risk germ-cell tumors
1Division of Medical Oncology, Veterans Affairs Medical Center, Palo Alto, California, USA.
Oncology (Williston Park, N.Y.)
|December 1, 2000
Abstract:
Testicular cancer is a highly curable cancer. However, 30% of patients are refractory to standard therapy and will need additional therapy. This article focuses on the use of high-dose chemotherapy in germ-cell tumors. High-dose chemotherapy use is discussed both in the refractory setting and as either first-salvage or first-line therapy. Various criteria for risk assessment are also discussed.